LSL logo

LSL Pharma Group Inc. Stock Price

TSXV:LSL Community·CA$44.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LSL Share Price Performance

CA$0.35
-0.06 (-14.63%)
CA$0.35
-0.06 (-14.63%)
Price CA$0.35

LSL Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very low risk and overvalued.

2 Risks
0 Rewards

LSL Pharma Group Inc. Key Details

CA$34.4m

Revenue

CA$28.9m

Cost of Revenue

CA$5.5m

Gross Profit

CA$11.0m

Other Expenses

-CA$5.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.043
15.94%
-15.93%
147.1%
View Full Analysis

About LSL

Founded
n/a
Employees
245
CEO
Francois Roberge
WebsiteView website
www.groupelslpharma.com

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. It offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, as well as natural health products in sachets, capsules, loose powder, blister packs, and liquids for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

Recent LSL News & Updates

Recent updates

No updates